Standout Papers

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases 2022 2026 2023 2024144
  1. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases (2022)
    Liyun He, Jialu Wang et al. JAMA Internal Medicine

Immediate Impact

1 from Science/Nature 69 standout
Sub-graph 1 of 22

Citing Papers

Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
2024 Standout
Tirzepatide for Obesity Treatment and Diabetes Prevention
2024 Standout
1 intermediate paper

Works of Na Yang being referenced

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases
2022 Standout

Author Peers

Author Last Decade Papers Cites
Na Yang 101 136 72 104 24 377
Rasha H. Mohamed 50 51 62 89 23 447
Nobuto Okamoto 71 78 96 120 23 337
Jace Nielsen 100 130 63 94 19 374
Chizuko Kitabayashi 38 90 99 95 21 449
Yuzhen Liang 39 125 55 111 29 395
Ning Li 57 81 85 111 28 381
Marwa A. Abdel-Dayem 40 61 42 133 14 346
Simona Imbriani 41 178 90 133 13 428
Marco Brogi 37 184 87 132 26 426
Mika Sakaki 80 92 95 87 26 405

All Works

Loading papers...

Rankless by CCL
2026